HIGHFDA DRUG
Dr. Reddy's Laboratories Recalled Succinylcholine Injection Over Safety Concerns
Dr. Reddy's Laboratories recalled 571 vials of Succinylcholine Chloride Injection on September 26, 2025. The recall stems from out-of-specification results during stability testing, indicating a decreased preservative concentration. The product is used for intravenous or intramuscular administration and is available by prescription only.
SUCCINYLCHOLINE
Out-of-Specification (OOS)